Loading...
Anteris Technologies Ltd
AMEUF•PNK
Healthcare
Medical - Devices
$5.70
$-3.18(-35.81%)

Financial performance has remained strong, with revenue growing from $2.35M in Q2 2023 to $2.13M in Q2 2024. Gross profit continued to perform well, with margins at 42% in the latest quarter. Operating income reached -$52.36M in Q2 2024, holding a steady -2462% margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at -$51.32M. Net income dropped to -$50.83M, keeping EPS at -$2.75. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan